Literature DB >> 5262259

Prolonged infusion of arabinosyl cytosine in childhood leukemia.

J J Wang, O S Selawry, T J Vietti, G P Bodey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5262259     DOI： 10.1002/1097-0142(197001)25:1<1::aid-cncr2820250102>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  9 in total

1.  Intra-arterial cancer chemotherapy with combined anticancer agents.

Authors:  S Fujimoto; T Miyoshi; Y Nomura; T Akao; B Ito
Journal:  Jpn J Surg       Date:  1973-03

2.  Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemia.

Authors:  Amit K Mitra; Kristine R Crews; Stanley Pounds; Xueyuan Cao; Tanya Feldberg; Yogita Ghodke; Varsha Gandhi; William Plunkett; M Eileen Dolan; Christine Hartford; Susana Raimondi; Dario Campana; James Downing; Jeffrey E Rubnitz; Raul C Ribeiro; Jatinder K Lamba
Journal:  J Pharmacol Exp Ther       Date:  2011-06-28       Impact factor: 4.030

3.  A phase II study of high-dose cytosine arabinoside in the treatment of acute leukaemia in adults.

Authors:  M J Barnett; A Z Rohatiner; T S Ganesan; M A Richards; A Miller; T A Lister
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 4.  Genetic factors influencing cytarabine therapy.

Authors:  Jatinder K Lamba
Journal:  Pharmacogenomics       Date:  2009-10       Impact factor: 2.533

5.  Perineal rhabdomyosarcoma in a newborn child: pathological and biochemical studies with emphasis on contractile proteins.

Authors:  H F Hildebrand; I Krivosic; X Grandier-Vazeille; D Tetaert; G Biserte
Journal:  J Clin Pathol       Date:  1980-09       Impact factor: 3.411

6.  Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide.

Authors:  M Gore; R Powles; A Lakhani; S Milan; J Maitland; G Goss; A Nandi; T Perren; G Forgeson; J Treleaven
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

7.  Role of Genetic Polymorphisms of Deoxycytidine Kinase and Cytidine Deaminase to Predict Risk of Death in Children with Acute Myeloid Leukemia.

Authors:  Aurora Medina-Sanson; Arturo Ramírez-Pacheco; Silvia Selene Moreno-Guerrero; Elisa María Dorantes-Acosta; Metzeri Sánchez-Preza; Alfonso Reyes-López
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

8.  Genome-wide association analysis identifies SNPs predictive of in vitro leukemic cell sensitivity to cytarabine in pediatric AML.

Authors:  Salma A Bargal; Roya Rafiee; Kristine R Crews; Huiyun Wu; Xueyuan Cao; Jeffrey E Rubnitz; Raul C Ribeiro; James R Downing; Stanley B Pounds; Jatinder K Lamba
Journal:  Oncotarget       Date:  2018-10-09

9.  Association of genetic polymorphisms in genes involved in Ara-C and dNTP metabolism pathway with chemosensitivity and prognosis of adult acute myeloid leukemia (AML).

Authors:  Ke-Wei Zhu; Peng Chen; Dao-Yu Zhang; Han Yan; Han Liu; Li-Na Cen; Yan-Ling Liu; Shan Cao; Gan Zhou; Hui Zeng; Shu-Ping Chen; Xie-Lan Zhao; Xiao-Ping Chen
Journal:  J Transl Med       Date:  2018-04-10       Impact factor: 5.531
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.